 MADISON, Wis. , Oct. 10, 2022 PRNewswire -- Exact Sciences Corp. Nasdaq: EXAS, a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its third quarter 2022 financial results after the close of the U.S. financial markets on November 3, 2022. 